SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

ONVO RSS Feed
Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Granddadx6
Search This Board:
Last Post: 8/26/2016 1:34:19 PM - Followers: 322 - Board type: Free - Posts Today: 1
WELCOME TO THE ORGANOVO BOARD


 
     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

COMPANY PROFILE via YouTube
http://www.youtube.com/watch?feature=player_embedded&v=-A-uH15bQZw

 
ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014


IR and Media Contacts:
Investor Relations Contact: ir@organovo.com
Media Contact: media@organovo.com

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994


For all the latest company information, details, news, please visit http://www.organovo.com

 
Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:

Science

Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.

 

World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

 

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

http://www.invetech.com.au/portfolio/life-sciences/3d-bioprinter-world-first-print-human-tissue/
http://techli.com/2012/07/organovo-bioprinting/#.
https://www.youtube.com/watch?v=1O3c3pUg0L8 (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ONVO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ONVO News: Securities Registration: Employee Benefit Plan (s-8) 04:32 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 08/19/2016 06:28:32 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 08/19/2016 06:27:11 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 08/19/2016 06:26:26 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 08/19/2016 06:25:40 PM
News News Alert: Securities Registration: Employee Benefit Plan (s-8) 08/26/2016 04:32:37 PM
PostSubject
#9373  Sticky Note ONVO 8K---EXCHANGE CHANGE; Granddadx6 07/26/16 08:13:34 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9530   Shares Short* 11,370,676 RandolRocketman 08/26/16 01:34:19 PM
#9529   Looks like about 73,000 shares.... WHP03 08/25/16 04:56:43 PM
#9528   Closed at $3.80 yesterday...$3.90 today, with a high WHP03 08/25/16 04:40:13 PM
#9527   Strong buying going into the close! Alvie 08/25/16 04:34:48 PM
#9526   Is there support at this level ($3.80) looking WHP03 08/24/16 04:34:03 PM
#9525   NASDAQ Short interest report, updated today: more than WHP03 08/24/16 04:17:10 PM
#9524   With this price action I am buying more WHP03 08/24/16 01:58:00 PM
#9523   NASDAQ Short Interest Report Due after today's close. WHP03 08/24/16 10:31:32 AM
#9522   Yes this is standard for ONVO. The board RandolRocketman 08/24/16 08:50:28 AM
#9521   The Form 4s filed by ONVO this afternoon WHP03 08/23/16 10:07:19 PM
#9520   $ONVO Another version with different MA http:/ $Pistol Pete$ 08/22/16 03:17:37 PM
#9519   $ONVO Daily & Weekly Chart http://stockcharts $Pistol Pete$ 08/22/16 03:14:17 PM
#9518   Don't get me wrong - I definitely see WHP03 08/22/16 11:32:15 AM
#9517   There are two more upgrades also listed on trailgirl 08/22/16 10:37:05 AM
#9516   I'm just pasting what I see on my RandolRocketman 08/22/16 10:37:00 AM
#9515   This is Friday's Thomson report, when they still WHP03 08/22/16 09:58:05 AM
#9514   Thomson Reuters/Verus upgrades ORGANOVO HOLDINGS INC from HOLD RandolRocketman 08/22/16 09:52:39 AM
#9513   That's interesting, as they previously had a Hold WHP03 08/22/16 09:26:13 AM
#9512   Ford Equity Research upgrades ORGANOVO HOLDINGS INC from RandolRocketman 08/22/16 08:10:31 AM
#9511   BornAtNight - just posted an answer on your WHP03 08/20/16 04:28:01 PM
#9510   From Page 2 of the recent 8-K: WHP03 08/20/16 04:24:33 PM
#9509   Table II(Derivative Securities...)...Box 2 "Conversion or Exercise Price wiredawg 08/20/16 02:33:12 PM
#9508   Richard Maroun 15k shares & 37K warrants Kirk Malloy BuckeyeStocks 08/20/16 09:53:06 AM
#9507   I read it as the shares were given trailgirl 08/20/16 08:28:43 AM
#9506   Someone please confirm I am reading the filings BornAtNight 08/19/16 06:48:46 PM
#9505   Thanks for the responses WHP and Granddad. trailgirl 08/19/16 04:28:43 PM
#9504   Topped up my core position today. I'm confident Granddadx6 08/19/16 03:20:03 PM
#9503   Anyone's guess... WHP03 08/19/16 03:14:09 PM
#9502   Yikes! How low will it go? trailgirl 08/19/16 03:02:51 PM
#9501   Well, so much for ending the week north WHP03 08/19/16 02:38:05 PM
#9500   Well stated! I'm waiting on another reloading zone. Granddadx6 08/18/16 06:53:24 PM
#9499   $4.99 (52 wk high) to $4.15 (today's low) WHP03 08/18/16 06:48:57 PM
#9498   Yes, that was the last data point from WHP03 08/18/16 11:35:04 AM
#9497   Shares Short* 10,806,024 RandolRocketman 08/18/16 11:03:14 AM
#9496   It will be very interesting to see how WHP03 08/18/16 10:58:02 AM
#9495   Looks like the new line to hold is WHP03 08/18/16 10:29:54 AM
#9494   I agree it will be quite sometime before CIMA7 08/18/16 10:06:36 AM
#9493   It's easy to speculate. But it's very exciting RandolRocketman 08/18/16 09:45:22 AM
#9492   I believe the next announcement (Q1) in this WHP03 08/18/16 09:35:12 AM
#9491   The reason I bolded the Mark Kessel is RandolRocketman 08/18/16 09:16:55 AM
#9490   Organovo Appoints Two New Members to Board of Directors RandolRocketman 08/18/16 09:07:40 AM
#9489   Organovo Appoints Two New Members to Board of BuckeyeStocks 08/18/16 09:07:00 AM
#9488   ONVO 8K; Granddadx6 08/18/16 08:58:27 AM
#9487   Will anyone be attending this... I'll be in bigideaportugal 08/17/16 04:56:50 PM
#9486   I hope we'll hear some good things from WHP03 08/17/16 03:53:07 PM
#9485   Just got to love it when a plan RandolRocketman 08/17/16 02:35:43 PM
#9484   Could be the shorts jumping back in on Alvie 08/17/16 11:58:12 AM
#9483   I feel ya. Been holding this stock since RandolRocketman 08/17/16 11:19:18 AM
#9482   I've been doing that for the last week, WHP03 08/17/16 11:11:50 AM
#9481   Could be a nice dip to buy more. RandolRocketman 08/17/16 11:09:44 AM
PostSubject